» Articles » PMID: 15294893

CA Repeats in the 3'-untranslated Region of Bcl-2 MRNA Mediate Constitutive Decay of Bcl-2 MRNA

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2004 Aug 6
PMID 15294893
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

An AU-rich element (ARE) in the 3'-untranslated region (UTR) of bcl-2 mRNA has previously been shown to be responsible for destabilizing bcl-2 mRNA during apoptosis through increasing AUF1 binding. In the present study, we investigated the effect of the region upstream of the ARE on bcl-2 mRNA stability using serial deletion constructs of the 3'-UTR of bcl-2. Deletion of 30 nucleotides mostly consisting of the CA repeats, located upstream of the ARE, resulted in the stabilization of bcl-2 mRNA abundance, in the absence or presence of the ARE. The specificity of the CA repeats in terms of destabilizing bcl-2 mRNA was proven by the substituting the CA repeats with other alternative repeats of purine/pyrimidine, but this had no effect on the stability of bcl-2 mRNA. CA repeats alone, however, failed to confer instability to bcl-2 or gfp reporter mRNAs, indicating a requirement for additional sequences in the upstream region of the 3'-UTR. Serial deletion and replacement of a part of the region upstream of the CA repeats revealed that the entire 131-nucleotide upstream region is an essential prerequisite for the CA repeat-dependent destabilization of bcl-2 mRNA. Unlike the ARE, CA repeat-mediated degradation of bcl-2 mRNA was not accelerated upon apoptotic stimulus. Moreover, the upstream sequences and CA repeats are conserved among mammals. Collectively, CA repeats contribute to the constitutive decay of bcl-2 mRNA in the steady states, thereby maintaining appropriate bcl-2 levels in mammalian cells.

Citing Articles

Associations of BCL2 CA-Repeat Polymorphism and Breast Cancer Susceptibility in Isfahan Province of Iran.

Ghorbani F, Javadirad S, Amirmahani F, Fatehi Z, Tavassoli M Biochem Genet. 2020; 59(2):506-515.

PMID: 33151448 DOI: 10.1007/s10528-020-10013-y.


CHIP buffers heterogeneous Bcl-2 expression levels to prevent augmentation of anticancer drug-resistant cell population.

Tsuchiya M, Nakajima Y, Waku T, Hiyoshi H, Morishita T, Furumai R Oncogene. 2014; 34(35):4656-63.

PMID: 25435366 DOI: 10.1038/onc.2014.387.


Role of 3'-untranslated region translational control in cancer development, diagnostics and treatment.

Vislovukh A, Rivera Vargas T, Polesskaya A, Groisman I World J Biol Chem. 2014; 5(1):40-57.

PMID: 24600513 PMC: 3942541. DOI: 10.4331/wjbc.v5.i1.40.


Genetic variation in BCL2 3'-UTR was associated with lung cancer risk and prognosis in male Chinese population.

Xu P, Liu L, Wang J, Zhang K, Hong X, Deng Q PLoS One. 2013; 8(8):e72197.

PMID: 23977251 PMC: 3745400. DOI: 10.1371/journal.pone.0072197.


FUBP3 interacts with FGF9 3' microsatellite and positively regulates FGF9 translation.

Gau B, Chen T, Shih Y, Sun H Nucleic Acids Res. 2011; 39(9):3582-93.

PMID: 21252297 PMC: 3089454. DOI: 10.1093/nar/gkq1295.